Valuation: Alcon

Market Cap 3.53TCr 3.03TCr 2.84TCr 2.6TCr 4.9TCr 3,36500Cr 4.92TCr 34TCr 13TCr 1,69800Cr 13TCr 13TCr 5,62300Cr P/E 2026 *
43.8x
P/E 2027 * 26.6x
Enterprise Value 3.78TCr 3.25TCr 3.05TCr 2.78TCr 5.25TCr 3,60800Cr 5.28TCr 36TCr 14TCr 1,82000Cr 14TCr 14TCr 6,02800Cr EV / Sales 2026 *
3.41x
EV / Sales 2027 * 3.12x
Free-Float
97.34%
Yield 2026 *
0.5%
Yield 2027 * 0.56%
Manager TitleAgeSince
Chief Executive Officer 60 01/07/2018
Director of Finance/CFO 58 08/04/2019
Chief Tech/Sci/R&D Officer - 01/01/2025
Director TitleAgeSince
Director/Board Member 60 -
Chairman 70 01/07/2018
Director/Board Member 63 01/02/2019
Change 5-day change 1-year change 3-year change Capi.($)
+19.94%0.00% - - 3.54TCr
+0.03%-2.87%-40.86%-8.53% 8.54TCr
-0.20%-2.88%-10.51%-20.42% 3.54TCr
-0.49%-4.07%-1.09%-21.72% 1.42TCr
-1.34%+1.18% - - 1.2TCr
-0.76%+9.74%-10.58%+743.48% 277.66Cr
+2.33%-2.66%-42.86%-56.92% 145.99Cr
+1.78%+3.04%+16.95%+10.70% 90Cr
-0.58%-1.30%+51.48%-8.18% 89Cr
+0.15%+3.10% - - 89Cr
Average +0.11%+1.03%-5.35%+91.20% 1.71TCr
Weighted average by Cap. -0.11%-1.61%-27.70%+1.59%

Financials

2026 *2027 *
Net sales 1.11TCr 951.78Cr 893.34Cr 815.91Cr 1.54TCr 1,05800Cr 1.55TCr 11TCr 4.1TCr 53TCr 4.16TCr 4.07TCr 1,76700Cr 1.18TCr 1.01TCr 948.48Cr 866.28Cr 1.63TCr 1,12300Cr 1.64TCr 11TCr 4.35TCr 57TCr 4.42TCr 4.32TCr 1,87600Cr
Net income 76Cr 66Cr 62Cr 56Cr 106.12Cr 7.29TCr 106.63Cr 728.58Cr 282.35Cr 3.68TCr 286.94Cr 280.71Cr 12TCr 125.89Cr 108.05Cr 101.42Cr 93Cr 174.81Cr 12TCr 175.66Cr 1.2TCr 465.13Cr 6.06TCr 472.69Cr 462.43Cr 20TCr
Net Debt 254.48Cr 218.42Cr 205.01Cr 187.24Cr 353.37Cr 24TCr 355.08Cr 2.43TCr 940.23Cr 12TCr 955.5Cr 934.76Cr 41TCr 144.99Cr 124.45Cr 116.81Cr 106.68Cr 201.34Cr 14TCr 202.31Cr 1.38TCr 535.71Cr 6.98TCr 544.41Cr 532.59Cr 23TCr
Logo Alcon
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (55.7%): consumables (52.7% of net sales), implantable products (31%) and other products (16.3%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (44.3%): contact lenses (60.6% of sales) and eye care products (39.4%; eye drops and ophthalmic ointments, etc.). At the end of 2025, the group operated 17 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (45.1%), Japan (5.9%), China (5.5%), and Other (42.8%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AAA